pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
News | Timely industry updates for pharma and biotech leaders
2 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
About pharmaphorum
2 days ago · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
Deep Dive: AI 2024 | pharmaphorum
Dec 6, 2024 · Deep Dive into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and the promise ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Deep-Dive | pharmaphorum
6 days ago · Dear Readers, In an era where technological buzzwords fly faster than medical diagnoses, artificial intelligence (AI) has become the ultimate conversation starter – and stopper.
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those questioned, during a period which has seen the first gene therapies marketed, as …
Pharma and the ongoing battle against AI drift | pharmaphorum
Dec 5, 2024 · A study published in Nature, noted that it is less common for the input data to be monitored for data drift (systemic changes to input distributions) and found that monitoring performance alone is ...
Pills and polls: What the 2024 election means for pharma
President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per-month out-of-pocket ...
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
5 days ago · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth analysis.